Oragenics Inc.

OGEN | AMEX

Price Alert Chart Builder DCF Calculator

$0.52

$0 (+0.02%)

Sep 22, 2026, 3:59 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.02%

(1D)

Rating

Updated: Aug 10, 2026

25.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $2.35M

1D Range

0.50 0.53

52W Range

0.48 1.45

Valuation (TTM)

PE -0.13

PB 0.59

EV/EBITDA 0.24

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -474.6%

SBC Adj. FCF Yield -479.7%

SBC Impact -1.1%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 28.1% | 11.9%

FCF 3Y | 5Y -18.1% | 13.9%

Returns

ROA -183.6%

ROE -144.2%

ROIC -279.5%

Financial Health

Net Cash

$3.86M

Current Ratio 3.01

Interest Coverage -561.90

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two vaccine candidates designed to combat the ...

Sector Healthcare

Industry Biotechnology

Employees 3

IPO Date Feb 24, 2004

Website www.oragenics.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.